New study aims to catch diabetic eye disease earlier with advanced testing
NCT ID NCT06821399
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will enroll nearly 3,000 people with type 2 diabetes to improve how diabetic retinopathy (an eye disease) is diagnosed and managed. Researchers will use eye exams, blood tests, and continuous glucose monitors to build better models for predicting and treating the condition. The goal is to create personalized care plans that slow or prevent vision loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better early warning systems and personalized treatment plans for diabetic retinopathy, potentially preventing vision loss.
What could go wrong
This is an observational study, so it won't test a new treatment. The results may not apply to all patients, and the models need further validation before use in clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai general hosptial
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The first hosptial of lanzhou university
RECRUITINGLanzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The forth people's hosptial of shenyang
RECRUITINGShenyang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••